MicroRNA-21 Identified as Predictor of Cancer Outcome: A Meta-Analysis

Por Zhu, Wenjie, Xu, Binghe
Publicado em 2014

Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study

Por Zhu, Wenjie, Xu, Binghe
Publicado no PLoS One (2015)

In Reply

Por Xu, Binghe, Seidman, Andrew, Chan, Stephen
Publicado no Oncologist (2015)

Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities

Por Hong, Ruoxi, Dai, Zhen, Zhu, Wenjie, Xu, Binghe
Publicado no PLoS One (2015)

Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience

Por Xu, Shuping, Ramos-Suzarte, Mayra, Bai, Xianhong, Xu, Binghe
Publicado no Oncotarget (2016)

The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis

Por Wang, Wenna, Zhu, Wenjie, Du, Feng, Luo, Yang, Xu, Binghe
Publicado no Sci Rep (2017)

Age-Related Disparity in Immediate Prognosis of Patients with Triple-Negative Breast Cancer: A Population-Based Study from SEER Cancer Registries

Por Zhu, Wenjie, Perez, Edith A., Hong, Ruoxi, Li, Qing, Xu, Binghe
Publicado no PLoS One (2015)

The Efficacy and Safety of Programmed Cell Death 1 and Programmed Cell Death 1 Ligand Inhibitors for Advanced Melanoma: A Meta-Analysis of Clinical Trials Following the PRISMA Guid...

Por Guan, Xiuwen, Wang, Haijuan, Ma, Fei, Qian, Haili, Yi, Zongbi, Xu, Binghe
Publicado no Medicine (Baltimore) (2016)

A Pooled Analysis of Gemcitabine Plus Docetaxel Versus Capecitabine Plus Docetaxel in Metastatic Breast Cancer

Por Seidman, Andrew D., Chan, Stephen, Wang, Jin, Zhu, Chao, Xu, Cong, Xu, Binghe
Publicado em 2014

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer

Por Ma, Fei, Ding, Xiaoyan, Fan, Ying, Ying, Jianming, Zheng, Shan, Lu, Ning, Xu, Binghe
Publicado no PLoS One (2014)

There Is No Association between MicroRNA Gene Polymorphisms and Risk of Triple Negative Breast Cancer in a Chinese Han Population

Por Ma, Fei, Zhang, Ping, Lin, Dongxin, Yu, Dianke, Yuan, Peng, Wang, Jiayu, Fan, Yin, Xu, Binghe
Publicado em 2013

Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel

Por Li, Qian, Liu, Mei, Ma, Fei, Luo, Yang, Cai, Ruigang, Wang, Liming, Xu, Ningzhi, Xu, Binghe
Publicado em 2014

Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Pac...

Por Li, Qian, Liu, Mei, Ma, Fei, Luo, Yang, Cai, Ruigang, Wang, Liming, Xu, Ningzhi, Xu, Binghe
Publicado no PLoS One (2015)

Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From...

Por Zhang, Zhihui, Yuan, Peng, Guo, Huiqin, Zhao, Linlin, Ying, Jianming, Wang, Mingrong, Zhao, Huan, Pan, Qinjing, Xu, Binghe
Publicado no Medicine (Baltimore) (2015)

Prognostic Significance of Single Progesterone Receptor Positivity: A Comparison Study of Estrogen Receptor Negative/Progesterone Receptor Positive/Her2 Negative Primary Breast Can...

Por Fan, Ying, Ding, Xiaoyan, Xu, Binghe, Ma, Fei, Yuan, Peng, Wang, Jiayu, Zhang, Pin, Li, Qing, Luo, Yang
Publicado no Medicine (Baltimore) (2015)

A single-nucleotide polymorphism in the 3′-UTR region of the adipocyte fatty acid binding protein 4 gene is associated with prognosis of triple-negative breast cancer

Por Wang, Wenmiao, Yuan, Peng, Yu, Dianke, Du, Feng, Zhu, Anjie, Li, Qing, Zhang, Pin, Lin, Dongxin, Xu, Binghe
Publicado no Oncotarget (2016)

53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells

Por Hong, Ruoxi, Ma, Fei, Zhang, Weimin, Yu, Xiying, Li, Qing, Luo, Yang, Zhu, Changjun, Jiang, Wei, Xu, Binghe
Publicado no BMC Cancer (2016)

Erratum to: 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells

Por Hong, Ruoxi, Ma, Fei, Zhang, Weimin, Yu, Xiying, Li, Qing, Luo, Yang, Zhu, Changjun, Xu, Binghe, Jiang, Wei
Publicado no BMC Cancer (2016)

Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors

Por Xu, BingHe, Wu, YiLong, Shen, Lin, Ye, DingWei, Jappe, Annette, Cherfi, Azzeddine, Wang, Hui, Yuan, RuiRong
Publicado em 2011

Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer

Por Wang, Jiayu, Xu, Binghe, Yuan, Peng, Ma, Fei, Li, Qing, Zhang, Pin, Cai, Ruigang, Fan, Ying, Luo, Yang, Li, Qiao
Publicado no Medicine (Baltimore) (2015)